Evidence map›Paper›PMID 31352916›Full record

ArticleBJPsych open2019

Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial.

James Shearer, Thomas R Lynch, Rampaul Chamba, Susan Clarke, Roelie J Hempel, David G Kingdon, Heather O'Mahen, Bob Remington, Sophie C Rushbrook, Ian T Russell and 5 more

Open access · goldAbstract read
In one paragraph

Article in BJPsych open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 2 countries.

James ShearerLecturer in Health Economics,Institute of Psychiatry, Psychology & Neuroscience, King's College London,UK.ORCID https://orcid.org/0000-0002-1658-9767
Thomas R LynchEmeritus Professor of Clinical Psychology,University of Southampton,UK.ORCID https://orcid.org/0000-0003-1270-6097
Rampaul ChambaPatient and Public Representative,Member of Trial Management Committee responsible for Public & Patient Inclusion,West Midlands,UK.
Susan ClarkeVisiting Professor, Intensive Psychological Therapies Service,Dorset Healthcare University NHS Foundation Trust,UK.
Roelie J HempelSenior Research Fellow,University of Southampton; andRadically Open Ltd,London,UK.
David G KingdonProfessor of Mental Health Care Delivery, Department of Medicine,University of Southampton,UK.
Heather O'MahenSenior Lecturer in Clinical Psychology, Department of Psychology,University of Exeter,UK.
Bob RemingtonEmeritus Professor in Psychology,University of Southampton,UK.
Sophie C RushbrookConsultant Clinical Psychologist, Intensive Psychological Therapies Service,Dorset Healthcare University NHS Foundation Trust,UK.
Ian T RussellProfessor of Clinical Trials, Medical School,University of Swansea,UK.
Maggie StantonConsultant Clinical Psychologist, Psychological Services,Southern Health NHS Foundation Trust,UK.
Michaela SwalesConsultant Clinical Psychologist and Reader in Clinical Psychology, School of Psychology,University of Bangor,UK.
Alan WatkinsAssociate Professor of e-Trials Research, Medical School,University of Swansea,UK.
Ben WhalleyLecturer in Psychology, Cognition Institute, School of Psychology,University of Plymouth,UK.
Sarah ByfordProfessor of Health Economics,Institute of Psychiatry, Psychology & Neuroscience, King's College London,UK.ORCID https://orcid.org/0000-0001-7084-1495
University of Southampton · GBDorset HealthCare University NHS Foundation Trust · GBKing's College London · GBSwansea University · GBBangor University · GBNational Patient Safety Foundation · USOpen Data Institute · GBSouthern Health NHS Foundation Trust · GBUniversity of Exeter · GBUniversity of Plymouth · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRefractory depression is a major contributor to the economic burden of depression. Radically open dialectical behaviour therapy (RO DBT) is an unevaluated new treatment targeting overcontrolled personality, common in refractory depression, but it is not yet known whether the additional expense of RO DBT is good value for money.AimsTo estimate the cost-effectiveness of RO DBT plus treatment as usual (TAU) compared with TAU alone in people with refractory depression (trial registration: ISRCTN85784627).

methodWe undertook a cost-effectiveness analysis alongside a randomised trial evaluating RO DBT plus TAU versus TAU alone for refractory depression in three UK secondary care centres. Our economic evaluation, 12 months after randomisation, adopted the perspective of the UK National Health Service (NHS) and personal social services. It evaluated cost-effectiveness by comparing the net cost of RO DBT with the net gain in quality-adjusted life-years (QALYs), estimated using the EQ-5D-3L measure of health-related quality of life.

resultsThe additional cost of RO DBT plus TAU compared with TAU alone was £7048 and was associated with a difference of 0.032 QALYs, yielding an incremental cost-effectiveness ratio (ICER) of £220 250 per QALY. This ICER was well above the National Institute for Health and Care Excellence (NICE) upper threshold of £30 000 per QALY. A cost-effectiveness acceptability curve indicated that RO DBT had a zero probability of being cost-effective compared with TAU at the NICE £30 000 threshold.

conclusionsIn its current resource-intensive form, RO DBT is not a cost-effective use of resources in the UK NHS.Declaration of interestR.H. is co-owner and director of Radically Open Ltd, the RO DBT training and dissemination company. D.K. reports grants outside the submitted work from the National Institute for Health Research (NIHR). T.L. receives royalties from New Harbinger Publishing for sales of RO DBT treatment manuals, speaking fees from Radically Open Ltd, and a grant outside the submitted work from the Medical Research Council. He was co-director of Radically Open Ltd between November 2014 and May 2015 and is married to Erica Smith-Lynch, the principal shareholder and one of two directors of Radically Open Ltd. H.O'M. reports personal fees outside the submitted work from the Charlie Waller Institute and Improving Access to Psychological Therapy. S.R. provides RO DBT supervision through her company S C Rushbrook Ltd. I.R. reports grants outside the submitted work from NIHR and Health & Care Research Wales. M. Stanton reports personal fees outside the submitted work from British Isles DBT Training, Stanton Psychological Services Ltd and Taylor & Francis. M. Swales reports personal fees outside the submitted work from British Isles DBT Training, Guilford Press, Oxford University Press and Taylor & Francis. B.W. was co-director of Radically Open Ltd between November 2014 and February 2015.

Indexed as

chronic depressioncost-effectiveness analysisradically open dialectical behaviour therapy (RO DBT)Refractory depressiontreatment-resistant depression

Identifiers

PMID31352916
PMCPMC6669879
OpenAlexW2965174838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.